Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROLAPITANT vs ROSIGLITAZONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROLAPITANT vs ROSIGLITAZONE: Safety Overview

Metric ROLAPITANT ROSIGLITAZONE
Total FAERS Reports 873 45,976
Deaths Reported 252 4,661
Death Rate 28.9% 10.1%
Hospitalizations 155 23,675
Average Patient Age 61.4 yrs 60.2 yrs
% Female Patients 57.5% 42.8%
FDA Approval Date Oct 25, 2017 Jan 25, 2013
Manufacturer TerSera Therapeutics LLC N/A
Route ORAL N/A
Marketing Status Prescription Discontinued